169 related articles for article (PubMed ID: 799756)
21. Current aspects of tumor immunology. Preface and introduction.
Weiss DW
Isr J Med Sci; 1973 Mar; 9(3):205-16. PubMed ID: 4575649
[No Abstract] [Full Text] [Related]
22. Tumor immunity and immunotherapy.
Boura P; Kountouras J; Lygidakis NJ
Hepatogastroenterology; 2001; 48(40):1040-4. PubMed ID: 11490795
[TBL] [Abstract][Full Text] [Related]
23. Tumor immunology.
Stevenson H; Tsang KY
Immunol Ser; 1993; 58():497-515. PubMed ID: 8424991
[No Abstract] [Full Text] [Related]
24. [Immunological processes and their morphological manifestations in the development of tumors].
Ageev AK
Arkh Patol; 1974; 36(6):72-80. PubMed ID: 4137423
[No Abstract] [Full Text] [Related]
25. The role of antibody in tumor immunity.
Economou JS
Surg Gynecol Obstet; 1981 Sep; 153(3):417-31. PubMed ID: 7268622
[TBL] [Abstract][Full Text] [Related]
26. The immunotherapy of cancer.
Parker CW
Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047
[No Abstract] [Full Text] [Related]
27. [Rearrangements in cell populations in malignant growth].
Shuklinov VA
Eksp Onkol; 1984; 6(6):25-30. PubMed ID: 6396066
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of tumor-induced immunological deficiencies and their possible significance in relation to the use of immunopotentiators in tumor-bearing hosts.
Kerbel RS
Biomedicine; 1974 Jul; 21(7):253-61. PubMed ID: 4547979
[No Abstract] [Full Text] [Related]
29. Clinical aspects of cancer immunity.
Moore GE
Prog Clin Cancer; 1973; 5():107-20. PubMed ID: 4571116
[No Abstract] [Full Text] [Related]
30. Metastatic spread and "escape" from the immune defenses of the host.
Alexander P
Natl Cancer Inst Monogr; 1976 Nov; 44():125-9. PubMed ID: 1025472
[TBL] [Abstract][Full Text] [Related]
31. Tumor immunology.
Stevenson HC; Tsang KY
Immunol Ser; 1990; 50():513-33. PubMed ID: 2091767
[No Abstract] [Full Text] [Related]
32. [1 of the pathways for normalization of populations of malignant cells].
Shuklinov VA
Tsitologiia; 1985 Mar; 27(3):268-75. PubMed ID: 3887700
[TBL] [Abstract][Full Text] [Related]
33. Tumor rejection antigens and tumor specific cytotoxic T lymphocytes.
Toes RE; Offringa R; Feltkamp MC; Visseren MJ; Schoenberger SP; Melief CJ; Kast WM
Behring Inst Mitt; 1994 Jul; (94):72-86. PubMed ID: 7998917
[TBL] [Abstract][Full Text] [Related]
34. Induction and inhibition of host immunity to experimental neoplasms. Discussion.
Br J Cancer Suppl; 1973 Aug; 1():62-71. PubMed ID: 4804291
[No Abstract] [Full Text] [Related]
35. Tumour-associated antigens and tumour-host interactions.
Baldwin RW
Proc R Soc Med; 1971 Oct; 64(10):1039-42. PubMed ID: 4335921
[No Abstract] [Full Text] [Related]
36. Possible significance of immune recognition of preneoplastic and neoplastic cell surfaces.
Lappé MA
Natl Cancer Inst Monogr; 1972 Dec; 35():49-55. PubMed ID: 4659057
[No Abstract] [Full Text] [Related]
37. Analysis of cell membrane antigens using radioiodinated, purified antibodies. II. A factor in the serum of hamsters bearing SV 40 -induced tumors which reacts with antibodies to SV 40 -transformed cell membranes.
Kedar E; Spira G; Sulitzeanu D
Isr J Med Sci; 1973 Mar; 9(3):277-83. PubMed ID: 4350975
[No Abstract] [Full Text] [Related]
38. Nutrition and tumor immunity: divergent effects of antitumor antibody.
Bull DM
Cancer Res; 1975 Nov; 35(11 Pt. 2):3317-9. PubMed ID: 1104143
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of tumor immunity. An overview.
Cohen S; Cohen MC
Am J Pathol; 1978 Nov; 93(2):449-58. PubMed ID: 309731
[TBL] [Abstract][Full Text] [Related]
40. [Current and prospective problems in tumor immunology].
Pitzurra M
Boll Ist Sieroter Milan; 1971; 50(3):209-20. PubMed ID: 4947785
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
